Proketazin

Proketazin - General Information

Proketazin is an antipsychotic drug, used in hospitalized patients in the management of chronic schizophrenic psychoses.

Pharmacology of Proketazin

Proketazin is a phenothiazine antipsychotic agent with a piperazine side-chain.

Additional information about Proketazin

Proketazin Indication: Used in the treatment of acute or chronic schizophrenic reactions in hospitalized patients.
Mechanism Of Action: A yellow, powdered, phenothiazine antipsychotic agent used in the treatment of acute or chronic schizophrenia. The term "phenothiazines" is used to describe the largest of the five main classes of neuroleptic antipsychotic drugs. These drugs have antipsychotic and, often, antiemetic properties, although they may also cause severe side effects such as akathisia, tardive dyskinesia and extrapyramidal symptoms. Proketazin blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Carphenazine
Synonyms: Carfenazine; Carphenazin
Drug Category: Antipsychotics
Drug Type: Small Molecule; Approved

Other Brand Names containing Carphenazine: Procethazine; Proketazin; Proketazine;
Absorption: Not Available
Toxicity (Overdose): Not Available
Protein Binding: Not Available
Biotransformation: Not Available
Half Life: Not Available
Dosage Forms of Proketazin: Not Available
Chemical IUPAC Name: 1-[10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazin-2-yl]propan-1-one
Chemical Formula: C24H31N3O2S
Carphenazine on Wikipedia: Not Available
Organisms Affected: Humans and other mammals